Literature DB >> 24676248

Guidelines for the management of community-acquired pneumonia in the elderly patient.

J González-Castillo1, F J Martín-Sánchez, P Llinares, R Menéndez, A Mujal, E Navas, J Barberán.   

Abstract

The incidence of community-acquired pneumonia (CAP) increases with age and is associated with an elevated morbimortality due to the physiological changes associated with aging and a greater presence of chronic disease. Taking into account the importance of this disease from an epidemiological and prognostic point of view, and the enormous heterogeneity described in the clinical management of the elderly, we believe a specific consensus document regarding this patient profile is necessary. The purpose of the present work was to perform a review of the evidence related to the risk factors for the etiology, the clinical presentation, the management and the treatment of CAP in elderly patients with the aim of elaborating a series of specific recommendations based on critical analysis of the literature. This document is the fruit of the collaboration of different specialists representing the Spanish Society of Emergency Medicine and Emergency Care (SEMES), the Spanish Society of Geriatrics and Gerontology (SEGG), the Spanish Society of Chemotherapy (SEQ), the Spanish Society of Internal Medicine (SEMI), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) and the Spanish Society of Home Hospitalization (SEHAD).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676248

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  8 in total

Review 1.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02

2.  The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies.

Authors:  Yun-Fang Zhou; Bang-An Luo; Lu-Lu Qin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 3.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

4.  Impact of frailty on 30-day and 1-year mortality in hospitalised elderly patients with community-acquired pneumonia: a prospective observational study.

Authors:  Jia Luo; Wen Tang; Ying Sun; Chunyan Jiang
Journal:  BMJ Open       Date:  2020-10-31       Impact factor: 2.692

5.  Diagnostic Accuracy of Chest x-Ray and Ultrasonography in Detection of Community Acquired Pneumonia; a Brief Report.

Authors:  Ali Taghizadieh; Alireza Ala; Farzad Rahmani; Akbar Nadi
Journal:  Emerg (Tehran)       Date:  2015

6.  The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.

Authors:  Shuren Guo; Xiaohuan Mao; Ming Liang
Journal:  Respir Res       Date:  2018-10-01

7.  [Recommendations for the care of patients with community-acquired pneumonia in the Emergency Department].

Authors:  A Julián-Jiménez; I Adán Valero; A Beteta López; L M Cano Martín; O Fernández Rodríguez; R Rubio Díaz; M A Sepúlveda Berrocal; J González Del Castillo; F J Candel González
Journal:  Rev Esp Quimioter       Date:  2018-04-05       Impact factor: 1.553

Review 8.  Decalogue for the selection of oral antibiotics for lower respiratory tract infections.

Authors:  R Cantón; J Barberán; M Linares; J M Molero; J M Rodríguez-González-Moro; M Salavert; J González Del Castillo
Journal:  Rev Esp Quimioter       Date:  2022-01-19       Impact factor: 1.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.